Manufacturer record
Protech Telelinks Mouza Ogli: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Protech Telelinks Mouza Ogli (Himachal Pradesh) were declared Not of Standard Quality between September 2025 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: L2022410B, Bupivacaine Injection IP (exp Sep 2026). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to IP with respect to test for 'Particulate Matter' and is also not of standard quality for the reason stated. Listed in the November 2025 alert.
Records by type
4 records linked to Protech Telelinks Mouza Ogli in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Bupivacaine Injection IP | Batch L2022410BMfg Oct 2024 · Exp Sep 2026 | The sample does not conform to IP with respect to test for 'Particulate Matter' and is also not of standard quality for the reason stated under "Description".Description | CDL, KolkataCDSCO lab | Nov 2025 |
| Bupivacaine Injection IP | Batch L2022410BMfg Oct 2024 · Exp Sep 2026 | The sample does not conform to claim as per IP 2022 in respect to the Test of Particulate matter, DescriptionDescription | CDL, KolkataCDSCO lab | Oct 2025 |
| Bupivacaine Injection IP | Batch L2022410BMfg Oct 2024 · Exp Sep 2026 | sample does not conform to IP with respect to test for "Particulate matter" and "Description".Description | CDL, KolkataCDSCO lab | Sep 2025 |
| Amoxycillin & Potassium Clavulanate Injection IP 1200 mg | Batch D0092461AMfg Dec 2024 · Exp Nov 2026 | sample does not conform to IP with respect to the Assay of Clavulanic AcidAssay | CDL, KolkataCDSCO lab | Sep 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.